F13.2
Sedative, hypnotic or anxiolytic-related dependence
Clinical Classification Guidelines
Excludes Type 1
- sedative, hypnotic or anxiolytic-related abuse (F13.1-)
- sedative, hypnotic, or anxiolytic use, unspecified (F13.9-)
Excludes Type 2
- sedative, hypnotic, or anxiolytic poisoning (T42.-)
Medical Intelligence & Overview
ICD-10 Code F13.2 relates to a condition characterized by a psychological or physical reliance on sedative, hypnotic, or anxiolytic medications. These drugs are often prescribed to manage anxiety, sleep problems, or certain medical conditions. When dependence develops, individuals may find it difficult to stop or control the use of these medications despite experiencing negative effects. Recognizing this dependence is vital for seeking appropriate treatment and support.
Causes & Symptoms
Clinical Causes: Long-term use of prescribed sedative, hypnotic, or anxiolytic medications. Misuse or abuse of these medications beyond prescribed guidelines. Underlying mental health conditions, such as anxiety disorders or insomnia. Genetic predisposition to addiction or substance dependence. Psychological dependence developed due to relief from symptoms or emotional escape.
Key Symptoms: Craving or intense desire to take the medication. Persistent desire or unsuccessful attempts to cut down or control usage. Developing a tolerance, requiring higher doses to achieve the same effect. Withdrawal symptoms when not using the medication, such as agitation, anxiety, or sleep disturbances. Neglecting responsibilities or activities due to medication use. Continuing use despite awareness of health problems or adverse effects.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of dependence involves a comprehensive assessment by a healthcare professional, including a detailed medical history, medication usage patterns, and symptom evaluation. Medical providers may use standardized criteria and questionnaires to determine the presence and severity of dependence. Blood tests or urine screenings might be conducted to assess medication levels and rule out other substance misuse.
Treatment Protocols: Supervised tapering schedule to gradually reduce medication dependence. Psychotherapeutic interventions such as cognitive-behavioral therapy (CBT) to address underlying issues. Support groups and counseling to provide emotional support and coping strategies. Management of withdrawal symptoms through medical supervision, possibly including alternative medications. Addressing co-occurring mental health disorders that may contribute to dependence. Long-term follow-up to prevent relapse and support recovery.
Clinical Advice & FAQs
Billing Guidance
Is F13.2 a billable ICD-10 code?
Yes, F13.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.2?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic-related dependence and any associated comorbidities for accurate reporting.
Cite this Clinical Reference